AnalystsElmar KrausElmar Kraus's Stock Forecasts
AnalystsElmar Kraus
Sectors:
Industries:
Analyst Ranking
Top 42%
#2299 out of 5510 analysts
Average Return
+19.97%
Win Rate
80%4 out of 5
Risk vs Reward
Poor
Good
Elmar Kraus's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Pfizer IncPFE | +53.00% | $34.89 | $53.38 | 2021-02-04 - 2022-02-03 | Strong Buy |
Eli Lilly & CoLLY | +42.38% | $243.06 | $346.07 | 2022-01-21 - 2023-01-20 | Strong Buy |
Eli Lilly & CoLLY | +15.75% | $264.19 | $305.79 | 2021-08-05 - 2022-08-04 | Strong Buy |
Medtronic PLCMDT | +8.06% | $86.82 | $93.82 | 2020-03-25 - 2020-05-14 | Strong Buy |
Elmar Kraus Analyst Color
Get additional color on Elmar Kraus's coverage of popular stocks
Elmar Kraus's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Eli Lilly & CoLLY | 3 | Hold | $820.00 | N/A | Downgrades | 3 years ago |
Gsk PLCGSK | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Astrazeneca PLCAZN | 1 | Hold | N/A | N/A | Upgrades | 5 years ago |
Pfizer IncPFE | 1 | Strong Buy | $41.00 | N/A | Upgrades | 6 years ago |
Medtronic PLCMDT | 2 | Hold | $92.00 | N/A | Downgrades | 6 years ago |
Gilead Sciences IncGILD | 2 | Strong Buy | N/A | N/A | Upgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.